• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Model Number RUBELLA IGG
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/22/2023
Event Type  malfunction  
Event Description
The initial reporter questioned positive results for 1 patient sample tested for elecsys rubella igg rubella igg on a cobas e 801 analytical unit.The initial result from the e801 analyzer was 155 iu/ml positive.The repeat on the same analyzer was 174 iu/ml positive.The sample was sent to an external laboratory for testing by the vidas method and the rubella igg result was 9.74 iu/ml negative.It is not known if the questionable positive results were reported outside of the laboratory.The e801 analyzer serial number was (b)(4).
 
Manufacturer Narrative
The sample was requested for investigation.The sample was received for investigation and tested on an e801 module.The rubella igg result was 135 iu/ml positive.The rubella igm result was 0.238 coi negative.The customer¿s rubella igg results were reproduced.The investigation is ongoing.
 
Manufacturer Narrative
The patient sample was investigated further.The platelia rubella igg result was positive.The mikrogen recomblot rubella igg result was positive.The sample was tested with a neutralization assay.The sample was neutralizable (positive for specific anti-rubella igg antibodies).Based on the investigation results, the patient sample was determined to be correctly positive for rubella igg.The reagent performed within specification.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS RUBELLA IGG
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16666635
MDR Text Key312862334
Report Number1823260-2023-01083
Device Sequence Number1
Product Code LFX
UDI-Device Identifier04015630940240
UDI-Public04015630940240
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberRUBELLA IGG
Device Catalogue Number07027770190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/10/2023
Initial Date FDA Received04/03/2023
Supplement Dates Manufacturer Received06/15/2023
Supplement Dates FDA Received07/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-